Antipsychotic Use by Newly Diagnosed Patients Drops After FDA Warnings

Antipsychotic Use by Newly Diagnosed Patients Drops After FDA Warnings

296195

Antipsychotic Use by Newly Diagnosed Patients Drops After FDA Warnings

The use of antipsychotics by people with early Parkinson’s disease (PD) has fallen substantially since the U.S. Food and Drug Administration (FDA) issued warnings about treating dementia with these medications, according to a database study of patients in Wales. Black-box warnings, which indicate a risk of death or serious injury with a medication’s use, were placed by the agency on antipsychotics for dementia patients in 2005, and again in 2008, after clinical trials found that…

You must be logged in to read/download the full post.